Pharmaceutical Business review

Huifeng closes $2 million convertible debt financing

The debt is convertible into shares of common stock at $1 per share and the company intends to use the proceeds to fund acquisitions of synergistic companies within the Shaanxi Province, China.

Primary Capital acted as the sole placement agent for this transaction.